Equine Healthcare Market Size & Growth Forecast 2027–2036, By Segments (Product Type, Activity, Distribution Channel, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Equine Healthcare Market size was more than USD 5.03 Billion in 2026 and is set to grow at a 10.36% CAGR between 2027 and 2036, attaining USD 13.48 Billion by 2036. The industry revenue for 2027 is assessed at USD 5.47 Billion.

• Base Year Value (2026): USD 5.03 Billion
• CAGR (2027-2036): 10.36%
• Forecast Year Value (2036): USD 13.48 Billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Equine Healthcare Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America holds 34.87% share due to strong veterinary infrastructure, high horse ownership, and widespread use of preventive care, diagnostics, and advanced treatment services.
  • Asia Pacific’s 9.49% CAGR is driven by rising investment in veterinary care, growing equestrian activity, and increasing shift toward preventive health and structured horse management practices.

• Segment Momentum:

  • Pharmaceuticals accounted for 28.18% of the market in 2026 due to their broad use in managing infections, inflammation, pain, parasitic conditions, and ongoing health maintenance across equine care settings.
  • Orthobiologics is the fastest-growing product type as veterinarians and horse owners increasingly adopt regenerative approaches to improve recovery outcomes for musculoskeletal injuries in active and performance horses.

• Market Expansion Drivers:

  • Rising equine sports participation and performance demands increasing veterinary healthcare utilization.
  • Increasing prevalence of infectious and parasitic diseases in horse populations driving treatment demand.
  • Expanding equine nutrition, supplements, and preventive care adoption supporting long-term animal health.

• Leading Market Participants:

  Prominent companies in the equine healthcare market include Zoetis Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Elanco Animal Health Incorporated (United States), Dechra Pharmaceuticals PLC (United Kingdom), Merck & Co., Inc. (United States), Ceva Santé Animale (France), IDEXX Laboratories, Inc. (United States), Covetrus, Inc. (United States), Heska Corporation (United States), Cargill, Incorporated (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 5.03 Billion
  • 2027 Estimated Market Size: USD 5.47 Billion.
  • Projected Market Size: USD 13.48 Billion by 2036
  • Growth Forecasts: 10.36% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Pharmaceuticals (Product Type) | Sports/Racing (Activity) | Veterinary Hospitals & Clinics (Distribution Channel) | Parasitic Infections (Indication)
  • Emerging Opportunity Segment: Orthobiologics (Product Type) | Recreation (Activity) | E-commerce (Distribution Channel) | Musculoskeletal Disorders (Indication)

Market Growth Drivers and Industry Trends

Rising equine sports participation and performance demands increasing veterinary healthcare utilization

Growing participation in equine sports and increasing expectations for animal performance are supporting the equine healthcare market by raising the need for regular veterinary assessment, injury management, and performance-related care. Competition horses are subject to physical demands that can increase the importance of preventive examinations, rehabilitation, diagnostic services, and therapeutic interventions. Owners and trainers also place greater emphasis on maintaining mobility, fitness, and recovery, encouraging more frequent utilization of veterinary healthcare services around training and competition activities.

Increasing prevalence of infectious and parasitic diseases in horse populations driving treatment demand

The occurrence of infectious and parasitic diseases among horse populations is increasing the equine healthcare market demand for diagnostic, pharmaceutical, and veterinary treatment solutions. Disease prevention and timely intervention are particularly important in settings where horses are housed, transported, or managed in groups, as health conditions can affect multiple animals and disrupt routine activities. Greater attention to disease surveillance, parasite control, vaccination, and veterinary diagnosis is therefore increasing the use of healthcare products and services for maintaining horse health.

Expanding equine nutrition, supplements, and preventive care adoption supporting long-term animal health

Greater awareness of the relationship between nutrition, physical condition, and disease prevention is driving the equine healthcare market as owners increasingly incorporate supplements and preventive care into routine horse management. Nutritional products can be used to support areas such as joint function, digestive health, muscle condition, and overall wellness, while preventive programs can help identify or manage health concerns before they become more severe. This shift toward proactive care is broadening healthcare utilization beyond treatment of acute conditions.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising equine sports participation and performance demands increasing veterinary healthcare utilization	2.00%	Moderate	North America, Europe	High	Near Term
Increasing prevalence of infectious and parasitic diseases in horse populations driving treatment demand	1.80%	High	North America, Asia Pacific	High	Near Term
Expanding equine nutrition, supplements, and preventive care adoption supporting long-term animal health	1.50%	Moderate	Europe, North America, Asia Pacific	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America dominated the equine healthcare market with a 34.87% share in 2026, reflecting its well-established equestrian ecosystem, strong veterinary infrastructure, and high levels of expenditure on animal health and preventive care. The region benefits from widespread participation in recreational, sporting, breeding, and performance-related equine activities, creating consistent demand for diagnostics, therapeutics, nutritional support, and routine veterinary services. Advanced veterinary capabilities and greater awareness of preventive healthcare also encourage owners and operators to pursue early diagnosis and comprehensive management of equine health conditions. In addition, established supply chains and specialized veterinary expertise provide a strong foundation for continued market development.

Asia Pacific is emerging as the fastest-growing regional market, supported by expanding interest in equestrian sports, improving veterinary infrastructure, and increasing awareness of professional equine care. Growing investment in breeding, training, racing, and recreational riding is broadening the need for specialized healthcare services and products. Improvements in veterinary education and diagnostic capabilities are helping address previously underserved healthcare requirements, while rising disposable incomes in several markets are enabling greater spending on animal wellness and performance management. The gradual development of organized equestrian facilities and professional animal-care practices is further creating opportunities for suppliers of advanced equine healthcare solutions.

Key Country Insights

United States

Performance horse care ecosystem

In the U.S., equine healthcare market demand is driven by a large performance horse industry and advanced veterinary infrastructure. The U.S. emphasizes preventive care, advanced diagnostics, and sports medicine applications supporting racing, competition, and recreational equine populations.

Japan

Niche equine care specialization

In Japan, equine healthcare market demand is relatively niche but highly specialized, centered on racing and select recreational use. Japan emphasizes controlled veterinary care practices and targeted treatment solutions for performance and breeding horses.

South Korea

Emerging equine infrastructure

In South Korea, equine healthcare market demand is supported by emerging horse sports infrastructure and recreational equestrian development. South Korea focuses on expanding veterinary capabilities and preventive healthcare solutions for a growing equine population.

Germany

Veterinary precision treatment

In Germany, equine healthcare market activity is shaped by high standards in veterinary medicine and structured animal health systems. Germany prioritizes precision diagnostics and preventive treatment protocols, with strong focus on equine sports and recreational horse management.

France

Strong equestrian tradition base

In France, equine healthcare market activity is influenced by strong equestrian traditions and established veterinary networks. France emphasizes comprehensive horse health management, particularly for sport and leisure horses, supported by structured veterinary service ecosystems.

Italy

Recreational equine maintenance

In Italy, equine healthcare market demand is driven by recreational horse ownership and equestrian tourism. Italy prioritizes routine veterinary care and preventive treatments, with steady demand for maintaining horse health across leisure and sport applications.

Segment Leadership and Growth Trends

 

Product Type Segment Analysis: Pharmaceuticals (Largest Segment) vs Orthobiologics (Fastest-Growing Segment)

Pharmaceuticals held the largest share of 28.18% in 2026 in the equine healthcare market, reflecting their broad use across disease prevention, infection management, pain control, inflammation management, and other routine veterinary needs. Pharmaceutical products remain an essential part of equine care because horses involved in athletic, recreational, and working activities require timely management of both acute and chronic health conditions. Increasing emphasis on preventive veterinary care and improved access to specialized animal health services are supporting continued demand. The availability of established therapeutic approaches for a wide range of equine conditions also gives pharmaceuticals a strong foundation across veterinary practices and horse-care environments.

Orthobiologics represent the fastest-growing product type as veterinarians and horse owners increasingly seek regenerative approaches that can support tissue repair and functional recovery. These therapies are particularly relevant to musculoskeletal conditions, where maintaining mobility and restoring performance are important considerations. Greater interest in advanced treatment options for tendon, ligament, joint, and other orthopedic injuries is encouraging adoption of biologically focused therapies. The increasing integration of regenerative medicine into equine veterinary practice, combined with growing awareness of approaches designed to support natural healing processes, is strengthening the growth prospects of orthobiologics.

Activity Segment Analysis: Sports/Racing (Largest Segment) vs Recreation (Fastest-Growing Segment)

Sports/Racing accounted for the largest share in 2026, making it the leading activity segment in the equine healthcare market, as performance horses require consistent veterinary support to maintain health, mobility, conditioning, and competitive readiness. Intensive physical activity can increase the importance of injury prevention, rehabilitation, nutritional management, and routine health monitoring. Owners and trainers involved in competitive equine activities are therefore more likely to invest in specialized veterinary care and advanced treatment approaches when performance or recovery is affected. The growing focus on maintaining athletic longevity and managing musculoskeletal health continues to reinforce the importance of the sports and racing segment.

Recreation is the fastest-growing activity segment as horses increasingly participate in leisure riding, trail activities, companionship, and other non-competitive uses that encourage owners to prioritize long-term animal health. Recreational horse owners are becoming more attentive to preventive veterinary care, mobility, nutrition, and overall well-being, expanding demand beyond performance-focused applications. Greater awareness of equine wellness and improved access to veterinary services are encouraging owners to address health concerns earlier. This broader shift toward comprehensive care and quality of life is creating stronger opportunities for healthcare products and services within recreational equine populations.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product Type	Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services, Others	Pharmaceuticals	Orthobiologics
Activity	Sports/Racing, Recreation, Others	Sports/Racing	Recreation
Distribution Channel	Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities, Others	Veterinary Hospitals & Clinics	E-commerce
Indication	Musculoskeletal Disorders, Parasitic Infections, Equine Herpes Virus, Equine Viral Arteritis (EVA), Equine Influenza, West Nile Virus, Tetanus, Others	Parasitic Infections	Musculoskeletal Disorders

Competitive Landscape and Market Positioning

Prominent players in the equine healthcare market:

1. Zoetis Inc. (United States)

2. Boehringer Ingelheim International GmbH (Germany)

3. Elanco Animal Health Incorporated (United States)

4. Dechra Pharmaceuticals PLC (United Kingdom)

5. Merck & Co. Inc. (United States)

6. Ceva Santé Animale (France)

7. IDEXX Laboratories Inc. (United States)

8. Covetrus Inc. (United States)

9. Heska Corporation (United States)

10. Cargill Incorporated (United States)

The equine healthcare market is evolving through increased adoption of digital veterinary solutions, advanced diagnostics, and next-generation therapeutic approaches aimed at improving animal care standards. Industry participants are strengthening research capabilities and collaborative networks to enhance treatment accessibility and optimize healthcare delivery for equine populations. The growing integration of telemedicine platforms and data-driven health monitoring tools is also contributing to competitive differentiation across the equine healthcare market.

Industry Development/News

Company Name	Date	Key Development
Equine Care Group	May-26	Equine Care Group has expanded its international footprint into the United States through a strategic partnership with Salado Equine Medical Center in Texas. This acquisition marks the group’s first U.S. presence, enabling the integration of its veterinary service network and improving access to advanced diagnostic and treatment services within the North American equine healthcare market.
bioMérieux	Jun-25	bioMérieux has launched VETFIRE™, a ready-to-use PCR diagnostic kit designed for the rapid detection of seven equine infectious respiratory pathogens. By delivering results in under 20 minutes via the BIOFIRE® SPOTFIRE® platform, the technology enables veterinarians to make point-of-care decisions regarding treatment and quarantine, significantly improving the management of respiratory disease outbreaks in clinical and stable environments.
Chewy	Oct-25	Chewy has entered a definitive agreement to acquire the SmartEquine business from Covetrus. This acquisition incorporates SmartEquine’s premium portfolio of subscription-based supplements, personalized nutrition plans, and therapeutic products into Chewy’s healthcare ecosystem, strengthening the company's position in the high-margin equine wellness segment and enhancing its service offerings for equine owners nationwide.
Zomedica	Dec-25	Zomedica has launched a dedicated equine progesterone assay for its TRUFORMA® in-clinic biosensor platform. This addition expands point-of-care diagnostic capabilities for veterinarians and breeders, allowing for the quantitative assessment of reproductive function and pregnancy maintenance in mares, thereby improving breeding efficiency and clinical reproductive outcomes.
Sleip	Jun-24	Sleip has expanded the deployment of its AI-driven diagnostic platform designed for the detection and monitoring of equine lameness. By integrating artificial intelligence into standard veterinary workflows, the platform enables objective, data-driven analysis of gait abnormalities, supporting advanced clinical decision-making and improving the precision of performance monitoring for high-value equine athletes.